Search results for "HPMCP"

showing 2 items of 2 documents

Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems

2020

The in vivo dissolution of enteric-coated (EC) products is often overestimated by compendial in vitro dissolution experiments. It is of great interest to mimic the in vivo conditions as closely as possible in vitro in order to predict the in vivo behavior of EC dosage forms. The reason behind this is the overly high buffering capacity of the common compendial buffers compared to the intestinal bicarbonate buffer. However, a bicarbonate-based buffer is technically difficult to handle due to the need for continuous sparging of the media with CO2 to maintain the desired buffer pH. Therefore, bicarbonate buffers are not commonly used in routine practice and a non-volatile alternative is of inte…

HPMCPBicarbonatebiorelevantPharmaceutical Sciencelcsh:RS1-441dissolutionbicarbonatesurrogate bufferEudragitArticleDosage formlcsh:Pharmacy and materia medicachemistry.chemical_compoundmedicineDissolution testingenteric coatingcitrateDissolutionchemistry.chemical_classificationChromatographyHPMCASPolymersuccinateEnteric coatingchemistryIonic strengthDrug deliverymedicine.drugPharmaceutics
researchProduct

In Vitro Evaluation of Enteric-Coated HPMC Capsules—Effect of Formulation Factors on Product Performance

2020

A comparative study on different enteric-coated hard capsules was performed. The influence of different formulation factors like choice of enteric polymer, triethyl citrate (TEC) concentration (plasticizer), talc concentrations (anti-tacking agent), and different coating process parameters on the sealing performance of the capsule and the disintegration time were investigated. Furthermore, the influence of different disintegration test methods (with disc vs. without disc and 50 mM U.S. Pharmacopoeia (USP) buffer pH 6.8 vs. biopredictive 15 mM phosphate buffer pH 6.5) was evaluated. All formulations showed sufficient but not equivalent acid resistance when tested. Polymer type was the main f…

AQOATcapsulesPharmaceutical Sciencelcsh:RS1-441formulationhypromellose phthalate (HPMCP)engineering.materialTalcBuffer (optical fiber)Articlelcsh:Pharmacy and materia medicachemistry.chemical_compoundCoatingTriethyl citratemedicineEudragit L100-55biopredictiveenteric-coatingchemistry.chemical_classificationChromatographydisintegrationChemistryPlasticizerCapsulePolymerEnteric coatinghypromellose acetate succinate (HPMCAS)engineeringmedicine.drugPharmaceutics
researchProduct